New Zealand vs Sri Lanka: Prevalence rate of hypertension in men aged 30-79
New Zealand
34.4
in 2019
Sri Lanka
34.4
in 2019
New Zealand rank
133rd
Sri Lanka rank
133rd
Prevalence rate of hypertension in men aged 30-79 over time
- New Zealand
- Sri Lanka
How they compare
New Zealand currently reports 34.4 against 34.4 in Sri Lanka, a difference of 0.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was New Zealand ahead.
New Zealand ranks 133rd and Sri Lanka ranks 133rd of 195 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.68 | 31.38 | 5.3 | New Zealand |
| 2000s | 35.85 | 32.3 | 3.55 | New Zealand |
| 2010s | 34.93 | 33.65 | 1.28 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, New Zealand or Sri Lanka?
- New Zealand, at 34.4 against 34.4 in Sri Lanka as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between New Zealand and Sri Lanka?
- 0, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Sri Lanka?
- 30 years are reported by both, from 1990 to 2019.
- How do New Zealand and Sri Lanka rank globally for prevalence rate of hypertension in men aged 30-79?
- New Zealand ranks 133rd and Sri Lanka ranks 133rd of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.